Kymriah: England Becomes First In Europe To Say Yes To CAR-T

A new deal between Novartis and England’s National Health Service is one of the fastest funding approvals in the 70-year history of the NHS.

T-cells attacking cancer_1200x675
CAR-T therapy Kymriah could be made available to young patients in England in weeks

More from Market Access

More from Pink Sheet